LIVZON PHARMAC Net Income From Continuing Ops Over Time
| LP6 Stock | EUR 3.02 0.02 0.66% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LIVZON PHARMAC Performance and LIVZON PHARMAC Correlation. LIVZON |
Cross Equities Net Income From Continuing Ops Analysis
Compare LIVZON PHARMAC GRP and related stocks such as Sumitomo Rubber Indu, Archer Materials, and MP Materials Corp Net Income From Continuing Ops Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108 | 56.1 B | 56.1 B | 56.1 B | 56.1 B | 56.1 B | 56.1 B | 42.3 B | 49.5 B | 37.2 B | 13.2 B | 23 B | 30 B | 12.5 B | 38.5 B | 12.9 B | 11.7 B | 11.1 B |
| 38A | (675.1 K) | (675.1 K) | (675.1 K) | (675.1 K) | 5.5 B | 15.9 B | 17.8 B | 18.2 B | (1.7 M) | (2.8 M) | (2.8 M) | (14 M) | (9 M) | (4.8 M) | (7 M) | 18.2 B | 19.1 B |
| 55H0 | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 135 M | 289 M | 24.3 M | (65.4 M) | (58.9 M) | (55.9 M) |
| 12P | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 61.7 M | 47.7 M | 15.9 M | (16 M) | 166.6 M | (24.7 M) | (33.8 M) | 48.9 M | 32.7 M | 29.5 M | 25.4 M |
| 5NU | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | (673 M) | 1.6 B | 1.1 B | 333 M | 694 M | 170 M | 161.5 M |
| 14N1 | 1 B | 1 B | 1 B | 1 B | 1 B | 1 B | 1 B | 1 B | 1 B | 605.9 M | (1.4 B) | 805.6 M | 983.3 M | 630.7 M | 941.5 M | 1.1 B | 636.4 M |
LIVZON PHARMAC GRP and related stocks such as Sumitomo Rubber Indu, Archer Materials, and MP Materials Corp Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| LIVZON PHARMAC GRP | LP6 |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Headquarters Building, Zhuhai, |
| Exchange | Frankfurt Exchange |
EUR 3.02
Other Information on Investing in LIVZON Stock
LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.